HylaPharm is a university spinout company developing new targeted cancer therapies. HylaPlat ™ is a new cancer drug that has already shown efficacy in multiple mouse models, and in several dogs with large, naturally occurring cancers. It is the first targeted chemotherapy for potentially deadly, loc...
Use this information to figure out if this company is an ideal customer for you.
785.371.0147
2029 Becker Drive
Lawrence, 66047
HylaPharm's CEO is Laird Forrest
HylaPharm's CFO is Craig Paddock
HylaPharm's HQ is located at 2029 Becker Drive, Lawrence
HylaPharm's phone number is 785.371.0147
HylaPharm's official website is hylapharm.com
HylaPharm's revenue is $5M - $20M
HylaPharm has 11 - 50 employees
HylaPharm is in the industry of: Pharmaceuticals